Sca-1+ Cell-Based Gene Therapy with a Modified Fibroblast Growth Factor 2 (FGF2) Increased Endosteal/Trabecular Bone Formation in Mice

被引：0
|
作者：
Hall, Susan L. [1 ,2 ]
Lau, K. -H. William [1 ,2 ]
Chen, Shin-Tai [1 ,2 ]
Sheng, Matilda H. -C. [1 ,2 ]
Srivastava, Apurva K. [1 ,2 ]
Klamut, Henry J. [1 ,2 ]
Wergedal, Jon E. [1 ,2 ]
Gridley, Daila S. [3 ]
Mohan, Subburaman [1 ,2 ]
Baylink, David J. [2 ]
机构：
[1] Loma Linda Univ, Loma Linda VAMC, MDC, Loma Linda, CA 92350 USA
[2] Loma Linda Univ, Dept Med, Loma Linda, CA 92350 USA
[3] Loma Linda Univ, Dept Rad Med, Loma Linda, CA 92350 USA
来源：
MOLECULAR THERAPY | 2006年 / 13卷
关键词：
D O I：
10.1016/j.ymthe.2006.08.517
中图分类号：
Q81 [生物工程学（生物技术）]; Q93 [微生物学];
学科分类号：
071005 ; 0836 ; 090102 ; 100705 ;
摘要：
449
引用
收藏
页码：S173 / S173
页数：1
相关论文
共 50 条
  • [1] Sca-1+ hematopoietic cell-based gene therapy with a modified FGF-2 increased endosteal/trabecular bone formation in mice
    Hall, Susan L.
    Lau, Kin-Hing William
    Chen, Shin-Tai
    Wergedal, Jon E.
    Srivastava, Apurva
    Klamut, Henry
    Sheng, Matilda H-C
    Gridley, Daila S.
    Mohan, Subburaman
    Baylink, David J.
    MOLECULAR THERAPY, 2007, 15 (10) : 1881 - 1889
  • [2] Sca-1+ cell-based gene therapy with fibroblast growth factor-2 gene (but not BMP-4) dramatically increased endosteal bone formation in mice.
    Hall, S. L.
    Lau, K. H.
    Chen, S. T.
    Sheng, M. H.
    Gysin, R.
    Wergedal, J. E.
    Srivastava, A. K.
    Mohan, S.
    Baylink, D. J.
    JOURNAL OF BONE AND MINERAL RESEARCH, 2006, 21 : S34 - S34
  • [3] Stem Cell Antigen Positive (Sca-1+) Hematopoietic Cell-based Human Growth Hormone (hGH) Gene Therapy Enhanced Endosteal Bone Resorption in Mice.
    Hall, S. L.
    Chen, S. T.
    Mohan, S.
    Wergedal, J. E.
    Strong, D. D.
    Lau, K. H. W.
    JOURNAL OF BONE AND MINERAL RESEARCH, 2008, 23 : S431 - S431
  • [4] Opposing effects of Sca-1+ cell-based systemic FGF2 gene transfer strategy on lumbar versus caudal vertebrae in the mouse
    Lau, K-H W.
    Chen, S-T
    Wang, X.
    Mohan, S.
    Wergedal, J. E.
    Kesavan, C.
    Srivastava, A. K.
    Gridley, D. S.
    Hall, S. L.
    GENE THERAPY, 2016, 23 (06) : 500 - 509
  • [5] Opposing effects of Sca-1+ cell-based systemic FGF2 gene transfer strategy on lumbar versus caudal vertebrae in the mouse
    K-H W Lau
    S-T Chen
    X Wang
    S Mohan
    J E Wergedal
    C Kesavan
    A K Srivastava
    D S Gridley
    S L Hall
    Gene Therapy, 2016, 23 : 500 - 509
  • [6] Mesenchymal stem cell-based FGF2 gene therapy for acute lung injury induced by lipopolysaccharide in mice
    Zhao, Y. -F.
    Luo, Y. -M.
    Xiong, W.
    Ding, W.
    Li, Y. -R.
    Zhao, W.
    Zeng, H. -Z.
    Gao, H. -C.
    Wu, X. -L.
    EUROPEAN REVIEW FOR MEDICAL AND PHARMACOLOGICAL SCIENCES, 2015, 19 (05) : 857 - 865
  • [7] Erythroid Promoter Confines FGF2 Expression to the Marrow after Hematopoietic Stem Cell Gene Therapy and Leads to Enhanced Endosteal Bone Formation
    Meng, Xianmei
    Baylink, David J.
    Sheng, Matilda
    Wang, Hongjie
    Gridley, Daila S.
    Lau, K. -H. William
    Zhang, Xiao-Bing
    PLOS ONE, 2012, 7 (05):
  • [8] Novel Regulation of Fibroblast Growth Factor 2 (FGF2)-mediated Cell Growth by Polysialic Acid
    Ono, Sayaka
    Hane, Masaya
    Kitajima, Ken
    Sato, Chihiro
    JOURNAL OF BIOLOGICAL CHEMISTRY, 2012, 287 (06) : 3710 - 3722
  • [9] Prevalent expression of fibroblast growth factor (FGF) receptors and FGF2 in human tumor cell lines
    Chandler, LA
    Sosnowski, BA
    Greenlees, L
    Aukerman, SL
    Baird, A
    Pierce, GF
    INTERNATIONAL JOURNAL OF CANCER, 1999, 81 (03) : 451 - 458
  • [10] Oligodendrocyte lineage cell populations during myelination and remyelination in fibroblast growth factor (FGF2) knockout mice
    Armstrong, RC
    Le, TQ
    Vana, AC
    Murtie, JC
    JOURNAL OF NEUROCHEMISTRY, 2001, 78 : 28 - 28
12345